Moving forward: 6 points to expect with your APS preclinical research program
If you’re coming to APS with one of your first new medical devices, you may be uncertain how your preclinicalRead more.
New APS canine model enables better arthritis research
When APS scientists approached their company executives six years ago about initiating a new procedure for the study of arthritis,Read more.
APS’ human blood loop assay points to the future of hemocompatibility testing
APS has found a way to improve hemocompatibility testing for researchers seeking final FDA approval on blood-contacting medical devices —Read more.
APS’ incoming CSO brings years of experience in pharmaceutical and medical device research
As Dr. Jim Pomonis of APS gets ready to step into the next stage of his career, he can lookRead more.
World-class facilities empower preclinical success
To achieve truly revolutionary breakthroughs in the field of medical science, you need the right tools. At American Preclinical Services,Read more.
FDA Finalizes 510(k) Guidances on When to Submit a New 510(k)
On October 25, 2017, the FDA released two final guidance documents: Deciding When to Submit a 510(k) for a ChangeRead more.
FDA’s plan to engage the public in the agency’s new effort to strengthen and modernize FDA’s regulatory framework
On 07 September, 2017, FDA announced its plan to engage the public in the agencys new effort to strengthen andRead more.